Additional Paid-In Capital
Idexx Laboratories Additional Paid-In Capital increased by 1.9% to $1.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.8%, from $1.70B to $1.86B. Over 5 years (FY 2020 to FY 2025), Additional Paid-In Capital shows an upward trend with a 7.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A consistent increase is common for growth companies that frequently issue stock-based compensation or raise capital through equity markets.
Detailed definition
This represents the excess amount paid by investors for common shares above their stated par value. It is a critical com...
Peer comparison
This is a standard equity account for all publicly traded corporations, representing the cumulative historical premium paid by investors.
equity_additional_paid_in_capital_common_stockHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.34B | $1.36B | $1.38B | $1.40B | $1.42B | $1.44B | $1.46B | $1.49B | $1.52B | $1.54B | $1.57B | $1.60B | $1.63B | $1.65B | $1.67B | $1.70B | $1.73B | $1.79B | $1.83B | $1.86B |
| QoQ Change | — | +1.4% | +1.4% | +1.6% | +1.4% | +1.3% | +1.8% | +1.8% | +1.7% | +1.8% | +1.7% | +2.2% | +1.3% | +1.3% | +1.7% | +1.3% | +1.9% | +3.8% | +1.9% | +1.9% |
| YoY Change | — | — | — | — | +6.0% | +5.8% | +6.2% | +6.4% | +6.7% | +7.3% | +7.3% | +7.7% | +7.3% | +6.7% | +6.6% | +5.7% | +6.3% | +8.9% | +9.1% | +9.8% |
Additional Paid-In Capital at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's additional paid-in capital?
- Idexx Laboratories (IDXX) reported additional paid-in capital of $1.86B in Q1 2026.
- How has Idexx Laboratories's additional paid-in capital changed year-over-year?
- Idexx Laboratories's additional paid-in capital increased by 9.8% year-over-year, from $1.70B to $1.86B.
- What is the long-term trend for Idexx Laboratories's additional paid-in capital?
- Over 5 years (2020 to 2025), Idexx Laboratories's additional paid-in capital has grown at a 7.1% compound annual growth rate (CAGR), from $1.29B to $1.83B.
- What does additional paid-in capital mean?
- The total amount of capital received from shareholders in excess of the nominal par value of the stock.